Intouch Group and EVERSANA ENGAGE Named Gold and Silver Winners in Four Categories
CHICAGO – February 2, 2022 – EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced that both Intouch Group, an EVERSANA company and EVERSANA ENGAGE have been named winners in the 2021 PM360 Pharma Choice Awards.
Entries from Intouch Group earned gold in the professional campaign category, as well as two silver recognitions in the multichannel and variety categories. EVERSANA ENGAGE earned a silver award for work with Evoke Pharma and the “Spray Your Symptoms Away” campaign which promotes Gimoti™ (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
The marketing campaign highlights the novel route administration of GIMOTI to address a problematic disease where oral therapies aren’t properly absorbed due to delayed stomach emptying. It is part of EVERSANA’s integrated suite of outsourced services to commercialize and distribute GIMOTI in the United States.
“It’s tremendous to be recognized by PM360,” said Jim Lang, CEO at EVERSANA. “The combined creative team at both Intouch Group and EVERSANA ENGAGE demonstrate the power of our ability to deliver world-class, impactful campaigns that help connect patients with life changing therapies. Congrats to everyone from both teams on this achievement.”
PM360 is a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Since 2009, the PM360 Pharma Choice awards have served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry to choose the winners.
All submissions are placed online, and anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,000 votes were cast. Thirty-nine winners across 13 categories are featured in the most recent issue of PM360 magazine.
EVERSANA acquired Intouch Group in December 2021. Agencies from both firms will integrate, as EVERSANA ENGAGE joins forces with the Intouch agency network in 2022.
EVERSANA™ is the leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.
About Intouch Group
Intouch Group is a privately held full-service agency network, providing creative and media services, enterprise solutions and data analytics globally through ten affiliates in eight offices, including Intouch Solutions, Intouch Proto, Intouch Seven, Intouch Oxygen, Intouch International, Intouch Media, Intouch B2D, Intouch Analytics, Intouch Market Access, and Intouch MedComm. Collectively, Intouch Group employs more than 1,400 people. With a dedication to the life sciences, Intouch Group operates with the belief that there is no challenge too big to cure. Intouch is now part of EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry. Contact Intouch Group at [email protected] or visit them on the web at intouchg.com.